Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria
- PMID: 1693163
- DOI: 10.1099/0022-1317-71-5-1109
Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria
Abstract
We recently reported the enhanced immunogenicity of a peptide epitope when it was presented as a fusion protein with hepatitis B core antigen. In those experiments the fusion protein was expressed in vaccinia virus. We have now refined the system so that large amounts of highly immunogenic particles can be produced using a simple bacterial expression system. We describe the expression of three different viral epitopes as chimeric particles that induce good antibody responses to each epitope after one dose of low amounts of antigen. Finally we demonstrate that the immunogenicity is a reflection of both T helper cell sites within the core protein and also the particulate nature of the immunogens.
Similar articles
-
Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.Vaccine. 1991 Aug;9(8):595-601. doi: 10.1016/0264-410x(91)90248-5. Vaccine. 1991. PMID: 1722937
-
Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.J Biotechnol. 1996 Jan 26;44(1-3):91-6. doi: 10.1016/0168-1656(95)00118-2. J Biotechnol. 1996. PMID: 8717391 Review.
-
Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.Virology. 1994 May 1;200(2):547-57. doi: 10.1006/viro.1994.1217. Virology. 1994. PMID: 7513919
-
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.Nature. 1987 Nov 26-Dec 2;330(6146):381-4. doi: 10.1038/330381a0. Nature. 1987. PMID: 2446137
-
Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.Dev Biol Stand. 1994;82:151-8. Dev Biol Stand. 1994. PMID: 7958469 Review.
Cited by
-
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):174-196. doi: 10.1002/wnan.119. Epub 2010 Sep 24. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011. PMID: 20872839 Free PMC article. Review.
-
A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface.J Virol. 1994 Sep;68(9):5548-55. doi: 10.1128/JVI.68.9.5548-5555.1994. J Virol. 1994. PMID: 7520091 Free PMC article.
-
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.J Virol. 1992 Jan;66(1):106-14. doi: 10.1128/JVI.66.1.106-114.1992. J Virol. 1992. PMID: 1370083 Free PMC article.
-
Display of peptides on the surface of tobacco mosaic virus particles.Curr Top Microbiol Immunol. 2009;332:13-31. doi: 10.1007/978-3-540-70868-1_2. Curr Top Microbiol Immunol. 2009. PMID: 19401819 Free PMC article. Review.
-
Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions.J Virol. 1996 Jun;70(6):4045-52. doi: 10.1128/JVI.70.6.4045-4052.1996. J Virol. 1996. PMID: 8648742 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources